UPM Launches Non-animal Derived GrowInk 3D Printing Product Range at SLAS2020
The new GrowInk Bioinks product range is ideal for a wide range of bioprinting applications, the company says.
February 4, 2020
UPM launches non-animal derived, ready-to-use hydrogels that mimic the in vivo environment to support cell growth and differentiation. The new GrowInk Bioinks product range is being launched at SLAS2020, and is ideal for a wide range of bioprinting applications, including cell encapsulation and scaffold preparation for tissue engineering, drug discovery and regenerative medicine.
The two main components of GrowInk Bioinks—nanofibrillar cellulose and water—provide a fully defined matrix that can be mixed directly with cells and customized with additional growth factors or adhesion proteins. Compatible with a large variety of 3D printers, GrowInk Bioinks have been developed to provide imaging quality.
UPM’s GrowDex product range is also expanding, with a new sterile hydrogel—GrowDex-A—containing avidin-conjugated nanofibrillar cellulose. The product has been specifically developed to bind biotinylated molecules including proteins, peptides and antibiotics, and is suitable for use in various applications, such as spheroid formation for 3D cell culture.
To learn more about UPM’s latest advancements, visit booth #238 at SLAS2020.
Sources: Press materials received from the company and additional information gleaned from the company’s website.